CCCC — C4 Therapeutics Share News
0.000.00%
Last trade - 00:00- $391.22m
- $137.56m
- $35.95m
Brief: C4 Therapeutics Announces 2024 Priorities And Extended Cash Runway
C4 Therapeutics sheds nearly 30% of workforce; shares up
Brief: RA Capital Management Reports 9.9% Passive Stake In C4 Therapeutics As Of December 14
Brief: Commodore Capital LP Reports 7.7% Passive Stake In C4 Therapeutics Inc
U.S. STOCKS ON THE MOVE-Xpeng, Canopy Growth, ReShape Lifesciences
U.S. STOCKS ON THE MOVE-Southwest Airlines, Canopy Growth, US Steel
U.S. STOCKS ON THE MOVE-Vertex Pharma, Shattuck Labs, Airbnb
U.S. STOCKS ON THE MOVE-Pfizer, Tesla, Take-Two
C4 Therapeutics up on promising data from blood cancer therapy study
Brief: C4 Therapeutics Announces Positive Data From Cft7455 Phase 1 Trial In Relapsed/Refractory Multiple Myeloma
U.S. STOCKS ON THE MOVE-Expedia, Moderna, HubSpot
U.S. STOCKS ON THE MOVE-C4 Therapeutics, Eagle Bulk, SilverBow Resources
U.S. STOCKS ON THE MOVE-Wyndham Hotels, Alphabet, Candel Therapeutics
C4 Therapeutics rises on deal with Merck to develop cancer therapies
Brief: C4 Therapeutics Announces License And Research Collaboration With Merck
Brief: C4 Therapeutics Strengthens Board Of Directors With Owen Hughes Appointment
U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co., Costco Wholesale, Idexx Laboratories
C4 Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: C4 Therapeutics Q3 EPS USD -0.55